search icon

    Market Snapshot

    • S&P Futures

      3,809.5

    • Dow Futures

      30,868

    • Nasdaq Futures

      11,633.25

    blog search icon

    Alector, Inc.

    (NASDAQ:ALEC)

    $10.16

    $-0.05

    -0.49%

    Alector, Inc. Chart

    ALEC Stock Price Today

    Alector, Inc. (ALEC) stock declined over -0.49% intraday to trade at $10.16 a share on NASDAQ. The stock opened with a gain of 0.30% at $10.01 and touched an intraday high of $10.445, falling -0.49% against the last close of $10.21. The stock went to a low of $9.84 during the session.

    Stock Snapshot

    $10.21

    Prev. Close

    820.12 Million

    Market Cap

    $9.84

    Day Low

    $10.01

    Open

    82.1 Million

    Number of Shares

    $10.445

    Day High

    -

    P/E ratio

    -0.34

    EPS (TTM)

    8.96

    Cash Flow per Share

    8.03

    Free Float in %

    4.13

    Book Value

    455,151

    Volume

    Alector, Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-06-30$10.01$10.445$9.84$10.16443,409
    2022-06-29$10.13$10.28$9.86$10.21301,200
    2022-06-28$10.74$10.8$10.01$10.11611,500
    2022-06-27$10.75$11.035$10.49$10.74488,000
    2022-06-24$10.85$10.87$10.18$10.731,173,000
    2022-06-23$9.75$10.535$9.75$10.52682,900
    2022-06-22$8.76$9.91$8.76$9.7573,800
    2022-06-21$8.71$9.33$8.68$9.13579,900
    2022-06-17$8.21$8.74$8.12$8.531,267,300
    2022-06-16$8.12$8.12$7.54$8.07745,600

    Contact Details

    131 Oyster Point Boulevard
    Suite 600
    South San Francisco, CA 94080
    United States

    Webiste:ALEC

    415 231 5660

    Company Information

    Employees-

    Beta1.08

    Sales or Revenue207.08 Million

    5Y Sales Change246.30%

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The company also offers AL002, a product candidate that is in Phase II clinical trial for the treatment of Alzheimer's disease; and AL003, which is in Phase I clinical trial for the treatment of Alzheimer's disease. In addition, its products in development stage include AL044 that targets MS4A4A, a risk gene for Alzheimer's disease. Alector, Inc. has a collaboration agreement with Adimab, LLC for the research and development of antibodies; and a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of monoclonal antibodies, such as AL001 and AL101 to treat neurodegenerative diseases. The company was founded in 2013 and is headquartered in South San Francisco, California.

    Frequently Asked Questions

    icon

    What is the current Alector, Inc. (ALEC) stock price?

    Alector, Inc. (NASDAQ: ALEC) stock price is $10.16 as of the last check on Thursday, June 30. During the trading session, ALEC stock reached the peak price of $10.445 while $9.84 was the lowest point it dropped to.

    icon

    ALEC's industry and sector of operation?

    The NASDAQ listed ALEC is part of Biotechnology industry that operates in the broader Health Care sector. Alector, Inc. , a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases.

    icon

    Who are the executives of ALEC?

    Dr. Robert Paul M.D., Ph.D.
    Advisor
    Ms. Linda M. Rubinstein
    Interim CFO, Principal Financial Officer & Principal Accounting Officer
    Mr. Brian Sander J.D., Ph.D.
    Gen. Counsel
    Dr. Tillman Ulf Gerngross Ph.D.
    Co-Founder & Chairman

    icon

    What is the ALEC stock price today?

    ALEC stock traded closed the last session at $10.16, which is $-0.05 or -0.49% lower than its previous close of $10.21. ALEC's current trading price is 35.47% lower than its 52-week high of $43.32 where as its distance from 52-week low of 7.50% is -76.55%.

    icon

    How many employees does ALEC have?

    Number of ALEC employees currently stands at -. ALEC operates from 131 Oyster Point Boulevard, Suite 600, South San Francisco, CA 94080, United States.

    icon

    Link for ALEC official website?

    Official Webiste of $ALEC is: https://www.alector.com

    icon

    How do I contact ALEC?

    ALEC could be contacted at ALEC operates from 131 Oyster Point Boulevard, Suite 600, South San Francisco, CA 94080, United States, or at phone #415 231 5660 and can also be accessed through its website.

    icon

    How many shares of ALEC are traded daily?

    ALEC stock volume for the day was 455,151 shares while in the previous session number of ALEC shares traded was 443,409 . The average number of ALEC shares traded daily for last 3 months was 702 Thousands.

    icon

    How much did ALEC change today?

    The percentage change in ALEC stock occurred in the recent session was -0.49% while the dollar amount for the price change in ALEC stock was $-0.05.

    icon

    What price range ALEC stock been trading in?

    In the recent session, the day high for ALEC stock was $10.445 while the low for ALEC stock touched on the day was $9.84.

    icon

    What is the market cap of ALEC currently?

    The market value of ALEC currently stands at 820.12 Million with its latest stock price at $10.16 and 82.1 Million of its shares outstanding.